FORFIVO Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Forfivo, and when can generic versions of Forfivo launch?
Forfivo is a drug marketed by Twi Pharms and is included in one NDA. There is one patent protecting this drug.
The generic ingredient in FORFIVO is bupropion hydrochloride. There are thirty-eight drug master file entries for this compound. Seventy-four suppliers are listed for this compound. Additional details are available on the bupropion hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Forfivo
A generic version of FORFIVO was approved as bupropion hydrochloride by SENORES PHARMS on February 7th, 2000.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for FORFIVO?
- What are the global sales for FORFIVO?
- What is Average Wholesale Price for FORFIVO?
Summary for FORFIVO
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Drug Prices: | Drug price information for FORFIVO |
| What excipients (inactive ingredients) are in FORFIVO? | FORFIVO excipients list |
| DailyMed Link: | FORFIVO at DailyMed |
US Patents and Regulatory Information for FORFIVO
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Twi Pharms | FORFIVO XL | bupropion hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 022497-001 | Nov 10, 2011 | RX | Yes | Yes | 7,674,479 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
